|
Market Closed -
Oslo Bors
01:45:00 17/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 3.200 NOK | -3.61% |
|
-3.47% | -52.87% |
Company Valuation: Elliptic Laboratories ASA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,882 | 2,295 | 1,786 | 1,103 | 714.9 | 404.3 | - | - |
| Change | - | -20.36% | -22.15% | -38.24% | -35.2% | -43.45% | - | - |
| Enterprise Value (EV) 1 | 2,681 | 2,129 | 1,697 | 1,046 | 671.8 | 338.5 | 355.7 | 361.1 |
| Change | - | -20.57% | -20.32% | -38.34% | -35.79% | -49.62% | 5.09% | 1.51% |
| P/E | -252x | -71.1x | -47.3x | 116x | -5.14x | -13.8x | -69.8x | 62.6x |
| PBR | 8.41x | 7.04x | 5.82x | 3.39x | 3.8x | 1.92x | 1.96x | 1.89x |
| PEG | - | -0x | -2.9x | -1x | 0x | 0.2x | 0.9x | -0x |
| Capitalization / Revenue | 45.7x | 44.1x | 26.1x | 8.36x | 6.96x | 4.06x | 3.36x | 2.7x |
| EV / Revenue | 42.5x | 40.9x | 24.8x | 7.93x | 6.54x | 3.4x | 2.96x | 2.41x |
| EV / EBITDA | -948x | -69.1x | -50.6x | 41.7x | -32.5x | -381x | 20.5x | 10.1x |
| EV / EBIT | -241x | -50.5x | -34.1x | 222x | -14.8x | -12.9x | -44.2x | 41.2x |
| EV / FCF | -94.3x | -59x | - | - | -29.1x | -12.5x | -32.3x | 181x |
| FCF Yield | -1.06% | -1.69% | - | - | -3.44% | -7.98% | -3.09% | 0.55% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.11 | -0.31 | -0.36 | 0.09 | -1.32 | -0.2313 | -0.0458 | 0.0511 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 63.04 | 52.06 | 68.32 | 131.9 | 102.7 | 99.54 | 120.3 | 150 |
| EBITDA 1 | -2.829 | -30.81 | -33.52 | 25.12 | -20.68 | -0.8894 | 17.36 | 35.89 |
| EBIT 1 | -11.14 | -42.13 | -49.74 | 4.71 | -45.44 | -26.28 | -8.055 | 8.765 |
| Net income 1 | -11.16 | -32.04 | -37.85 | 8.96 | -139 | -30.08 | -6.028 | 6.793 |
| Net Debt 1 | -201 | -165.5 | -89.72 | -57.04 | -43.06 | -65.79 | -48.56 | -43.2 |
| Reference price 2 | 27.750 | 22.050 | 17.040 | 10.480 | 6.790 | 3.200 | 3.200 | 3.200 |
| Nbr of stocks (in thousands) | 103,842 | 104,074 | 104,838 | 105,275 | 105,287 | 126,337 | - | - |
| Announcement Date | 10/3/22 | 17/2/23 | 15/2/24 | 27/2/25 | 26/2/26 | - | - | - |
1NOK in Million2NOK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -13.83x | 3.4x | -380.6x | -.--% | 42.82M | |
| 26.83x | 9.91x | 16.18x | 0.73% | 3,928B | |
| 119.93x | 52.98x | 86.28x | -.--% | 447B | |
| 19.3x | 5.59x | 9.74x | 1.56% | 389B | |
| 216.99x | 19.31x | 56.52x | -.--% | 280B | |
| 28.38x | 5.66x | 17.83x | 1.34% | 259B | |
| 2273.9x | 37.98x | 124.23x | -.--% | 233B | |
| 90.05x | 8.93x | 23.9x | -.--% | 147B | |
| 54.82x | 14.71x | 38.75x | -.--% | 124B | |
| 13.44x | 3.57x | 7.47x | -.--% | 95.43B | |
| Average | 282.98x | 16.20x | 0.03x | 0.36% | 590.24B | |
| Weighted average by Cap. | 133.24x | 14.23x | 27.84x | 0.65% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ELABS Stock
- Valuation Elliptic Laboratories ASA
Select your edition
All financial news and data tailored to specific country editions
